FINWIRES · TerminalLIVE
FINWIRES

Research Alert: Spgi: Q1 Earnings Beat On Surging Ratings Revenue

By

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

SPGI posted solid Q1 2026 results with operating EPS of $4.97 vs. $4.37 YoY, beating the consensus by $0.15 after last quarter's miss. Revenue of $4.17B rose 10% YoY and beat the consensus by 2%, marking the third consecutive quarter of accelerating growth. We view this favorably as the Iran conflict had minimal impact on results. This validates management's confidence with improving business sentiment and reduced tariff uncertainty. Ratings was the standout performer with revenue surging 13% to $1.302B, due to robust issuance across both transaction (+15% to $712M) and non-transaction (+11% to $590M) revenue. Market Intelligence showed continued stabilization with 8% growth to $1.296B, though we believe AI disruption remains a long-term concern. Operating leverage was evident with adjusted operating margin expanding 100 bps to 51.8%, while the company returned $1.0B through repurchases and expects to return 100%+ of adjusted FCF in 2026.

Related Articles

Research

Research Alert: Sherwin-willams Q1 Eps Tops Expectations

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:SHW posted Q1 adjusted EPS of $2.35 versus $2.25 prior year, beating our $2.17 estimate and $2.27 consensus view. Net sales advanced 6.8% Y/Y to $5.67B, exceeding our 4.0% growth forecast, led by the Suvinil acquisition, favorable FX, and modest volume gains. The company demonstrated solid operational execution, with Paint Stores same-store sales improving to 2.4% from 1.2% in the prior year and Consumer Brands posting 19.2% growth, though North American DIY demand remained soft. Management maintained FY2026 guidance of low- to mid-single-digit sales growth with adjusted EPS projected at $11.50-$11.90, representing ~2.4% growth at the midpoint. Gross margin expanded 90bps to 49.1% on moderating raw material costs and improved pricing, though SG&A rose 9.8% as Suvinil integration costs pressured margins. The company also continued its shareholder return program in Q1, deploying $772.7M through dividends and share repurchases, despite acknowledging persistent macroeconomic uncertainty.

$SHW
Research

Research Alert: Ecolab Posts Solid Q1; Accelerated Growth; Near-term Margin Pressure Expected

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Ecolab reported Q1 sales of $4.1B (+10% Y/Y), $37M above consensus, with organic growth accelerating to +4% from +3% in Q4. Adjusted EPS of $1.70 (+13% Y/Y) met consensus, while operating margin expanded 70 bps to 16.7%, progressing toward the 20% target by 2027. Growth engines (20% of sales) showed strengthening momentum, with Global High-Tech delivering +25% organic growth from AI infrastructure and Life Sciences accelerating to +11% led by bioprocessing demand. Management maintained full-year EPS guidance of $8.43-$8.63 (+12% to +15%) but guided Q2 below estimates due to commodity cost pressures requiring energy surcharges. We view the High-Tech momentum as particularly significant given the multi-year AI data center runway, while the pending CoolIT acquisition reinforces ECL's end-to-end cooling capabilities. We see risk to 2H margin expansion if commodity costs remain elevated or if pricing implementation faces resistance, testing ECL's value proposition and customer relationships.

$ECL
Asia

China Resources Pharmaceutical Unit Sells 1.4 Billion Yuan Bonds

China Resources Pharmaceutical (HKG:3320) unit China Resources Pharmaceutical Commercial Group completed the issue of 1.4 billion yuan of 1.65% corporate bonds in China maturing in three years, according to a Tuesday Hong Kong bourse filing.The pharma firm intends to use proceeds for production expenditures, including the replenishment of working capital, repayment of debt, and project investments.

$HKG:3320